Board Meetings for COHANCE
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| COHANCE | Cohance Lifesciences Limited | 27 May 2024 | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 . | Board Meeting Intimation | |
| COHANCE | Cohance Lifesciences Limited | 27 May 2024 | Financial Results | To consider and approve the financial results for the period ended March 31, 2024 | |
| COHANCE | Cohance Lifesciences Limited | 05 Feb 2024 | Financial Results | To consider and approve the financial results for the period ended December 31, 2023 | |
| COHANCE | Cohance Lifesciences Limited | 05 Feb 2024 | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 05-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . | Board Meeting Intimation | |
| COHANCE | Cohance Lifesciences Limited | 09 Nov 2023 | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2023 and Other business. | Board Meeting Intimation | |
| COHANCE | Cohance Lifesciences Limited | 09 Nov 2023 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters | |
| COHANCE | Cohance Lifesciences Limited | 08 Aug 2023 | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Other business. | Board Meeting Intimation | |
| COHANCE | Cohance Lifesciences Limited | 08 Aug 2023 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 | |
| COHANCE | Cohance Lifesciences Limited | 25 May 2023 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2023 and other business matters | |
| COHANCE | Cohance Lifesciences Limited | 25 May 2023 | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 25-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Other business. | Board Meeting Intimation | |
| COHANCE | Cohance Lifesciences Limited | 06 Feb 2023 | Financial Results | To consider and approve the financial results for the period ended December 31, 2022 | |
| COHANCE | Cohance Lifesciences Limited | 08 Nov 2022 | Financial results | Suven Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 08-Nov-2022 to consider financial statements for the period ended September 2022 | |
| COHANCE | Cohance Lifesciences Limited | 02 Sept 2022 | Dividend | Suven Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 02-Sep-2022 to consider Dividend | |
| COHANCE | Cohance Lifesciences Limited | 08 Aug 2022 | Financial results | Suven Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 08-Aug-2022 to consider financial statements for the period ended June 2022 | |
| COHANCE | Cohance Lifesciences Limited | 09 May 2022 | Dividend/Financial results | Suven Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 09-May-2022 to consider financial statements for the period ended March 2022 and Dividend |